Literature DB >> 8951985

Endocrine responses during acute nicotine withdrawal.

W B Pickworth1, M H Baumann, R V Fant, R B Rothman, J E Henningfield.   

Abstract

Acute administration of nicotine increases cortisol and prolactin but the endocrine effects of tobacco withdrawal are unknown. In a residential, double-blind, placebo-controlled, crossover study, volunteers smoked ad lib for 4 days and underwent monitored tobacco abstinence for 3 days. On no-smoking days, patches delivering 0, 10, 20, or 30 mg nicotine were applied for 16 h. Daily plasma samples were analyzed for ACTH, cortisol, and prolactin. During nicotine abstinence (0 mg patch), circulating levels of ACTH, cortisol, and prolactin did not significantly change from ad lib smoking levels. Over all the patch conditions there was a significant effect of day, with modest but significant elevations of cortisol and ACTH levels on the second no-smoking day (Wed, 37 h abstinent). Prolactin levels increased during nicotine abstinence, but this effect was not significant. The observed endocrine changes did not correlate with physiologic, performance, or subjective measures of tobacco withdrawal. Our data indicate endocrine changes during acute tobacco withdrawal are transient and small. Thus, the present results do not support the use of ACTH as a treatment for tobacco cessation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951985     DOI: 10.1016/s0091-3057(96)00114-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Lifestyle, stress and cortisol response: Review II : Lifestyle.

Authors:  S Fukuda; K Morimoto
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

2.  Cortisol levels decrease after acute tobacco abstinence in regular smokers.

Authors:  Jordan A Wong; Wallace B Pickworth; Andrew J Waters; Mustafa al'Absi; Adam M Leventhal
Journal:  Hum Psychopharmacol       Date:  2014-03       Impact factor: 1.672

3.  Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers.

Authors:  Christine E Marx; William T Trost; Lawrence Shampine; Frederique M Behm; Louis A Giordano; Mark W Massing; Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2006-01-10       Impact factor: 4.530

4.  A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms.

Authors:  Michael Ussher; Paul Aveyard; Fiona Reid; Robert West; Phil Evans; Angela Clow; Frank Hucklebridge; Julie Fuller; Judith Ibison; Andrew Steptoe
Journal:  Psychopharmacology (Berl)       Date:  2011-02-09       Impact factor: 4.530

5.  Blunted opiate modulation of prolactin response in smoking men and women.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2009-12-05       Impact factor: 3.533

6.  Venous plasma nicotine correlates of hormonal effects of tobacco smoking.

Authors:  Yue Xue; Mark Morris; Lisong Ni; Sally K Guthrie; Jon-Kar Zubieta; Kimberly Gonzalez; Daniel S McConnell; Edward F Domino
Journal:  Pharmacol Biochem Behav       Date:  2010-01-25       Impact factor: 3.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.